ERF — Eurofins Scientific SE Balance Sheet
0.000.00%
- €10.46bn
- €13.86bn
- €6.95bn
- 89
- 41
- 79
- 85
Annual balance sheet for Eurofins Scientific SE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 912 | 515 | 487 | 1,221 | 614 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,389 | 1,581 | 1,597 | 1,617 | 1,609 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,518 | 2,319 | 2,313 | 3,066 | 2,452 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,575 | 1,830 | 2,168 | 2,297 | 2,560 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 8,576 | 9,332 | 10,084 | 10,889 | 10,888 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,696 | 1,856 | 1,772 | 2,122 | 2,110 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 4,885 | 4,685 | 5,301 | 5,811 | 5,550 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 3,690 | 4,648 | 4,782 | 5,078 | 5,339 |
| Total Liabilities & Shareholders' Equity | 8,576 | 9,332 | 10,084 | 10,889 | 10,888 |
| Total Common Shares Outstanding |